Jain PharmaBiotech, Feb 2012, Pages: 348
diagnostics for animals
5. Biotechnology-based Veterinary Medicine
Introduction
Biotechnology versus pharmaceutical products
Role of biotechnology in drugdiscovery and development
Cost of veterinary vs
Industry Experts, March 2011, Pages: 264
the market analysis for end-use application analysis of Bioinformatics – Biopharma & Diagnostics, Genomics, Agriculture, Chemicals and Environmental & Other. The report analyses the market in terms of USD Million
Jain PharmaBiotech, Feb 2012, Pages: 864
4. Biomarkers for DrugDiscovery & Development
Introduction
Biomarker technologies for drugdiscovery
Proteomics-based biomarkers for drugdiscovery
Chemoproteomics
Activity-based chemical
Frost & Sullivan, Dec 2008, Pages: 98
development.
Market Overview
Scope for New Drug Targets Discovery in the DrugDiscovery Industry Ridden with Challenges
Rising costs, a limited drug pipeline and the impeding loss of patent coverage
John Wiley and Sons Ltd, Feb 2011, Pages: 396
, classical medicinal chemistry approaches as well as chemicalgenomics strategies are discussed. On the clinical side, both current and future therapeutic application areas for kinase inhibitor drugs
Axis Research Mind, Feb 2011, Pages: 599
OF MICROARRAYS
TISSUE MICROARRAYS (TMAS)
ANTIBODY MICROARRAY
CELLULAR MICROARRAY
CHEMICAL COMPOUND MICROARRAY
POLYMER MICROARRAYS
F. BIOCHIPS APPLICATIONSDRUGDISCOVERY AND DEVELOPMENT
BIOCHIPS IN DRUG
Decision Resources, Inc., April 2007, Pages: 34
Biomarker Development
Figures:
1. Overall Five-Year Survival, by Stage
2. Potential Impact of Cancer Biomarkers in DrugDiscovery and
DrugDevelopment Processes
3. Applications of Biomarkers in Cancer
Global Industry Analysts, Inc., Aug 2011, Pages: 630
of major biotechnology and pharmaceutical companies.
DrugDiscovery firms are investing huge sums into HTS technology, providing a tremendous boost to the market and leading to simultaneous development
Jain PharmaBiotech, Feb 2012, Pages: 485
RNAi as a tool for assay development
Targeting human kinases with an siRNAi library
Challenges of drugdiscovery with RNAi
Express TrackSM siRNA DrugDiscovery Program
Genome-wide siRNA screens
Business Insights, Oct 2007, Pages: 161
&D paradigm by integrating drugdiscovery and development, areas with previously limited interaction. The primary goals of this approach are to terminate unsuccessful compounds earlier in their development
Jain PharmaBiotech, Feb 2012, Pages: 639
discovery for cancer. Cancer drug delivery is no longer simply wrapping up cancer drugs in a new formulations for different routes of delivery. The focus is on targeted cancer therapy. The newer approaches
Frost & Sullivan, May 2006
, the scientific community is exhibiting enhanced focus on the novel chemical and physical properties of nano-sized materials to develop new applications that will be beneficial to health. Within the realm of drug
TriMark Publications, May 2008, Pages: 160
Genomics is transforming the pharmaceutical industry. Companies are moving from drugdiscovery and development based on medicinal chemistry to the design of drugs based on information provided
Jain PharmaBiotech, Feb 2012, Pages: 534
Trials Database for AD
Alzheimer Research Consortium
The National Institute on Aging and AD research
5. DrugDiscovery & Development for Alzheimer Disease
Introduction
Categories of drugs
John Wiley and Sons Ltd, Jan 2010, Pages: 565
Leading experts illustrate how sophisticated computational data mining techniques can impact contemporary drugdiscovery and development
In the era of post-genomicdrugdevelopment, extracting
Global Industry Analysts, Inc., Aug 2011, Pages: 287
the research and development (R&D) activity within the industry. A large number of R&D projects are focused on use of metabolite profiles as crucial tools in drugdiscovery. The research extends potential cost-saving benefits
Global Industry Analysts, Inc., Jan 2011, Pages: 789
of Bioinformatics
Bioinformatics: Crucial for New DrugDevelopmentApplication of Bioinformatics to Oral Genomics
Importance of IP Protection Systems in Bioinformatics
4. INSIGHT INTO BIOINFORMATICS
Business Insights, Jan 2010, Pages: 179
DNA sequencing tools dominate the market
Protecting DNA sequencing technology
Applications of DNA sequencing
Drugdevelopment
Clinical trials
Whole genome testing
Toxicology prediction